{
  "title": "Spatial transcriptomics highlights B cells as key contributors to a complete and durable response to chemo-immunotherapy in a patient with resectable NSCLC.",
  "pmid": "40350207",
  "doi": null,
  "affiliations": [
    "Tumor Immunology and Immunotherapy Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.",
    "Tumor Immunology and Immunotherapy Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.",
    "Thoracic Surgery, IRCCS Regina Elena National Cancer Institute, Rome, Italy.",
    "Tumor Immunology and Immunotherapy Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.",
    "Second Division of Medical Oncology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.",
    "Tumor Immunology and Immunotherapy Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.",
    "Tumor Immunology and Immunotherapy Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.",
    "SAFU Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.",
    "Pathology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.",
    "Clinical Trials Unit: Phase 1 and Precision Medicine, IRCCS Regina Elena National Cancer Institute, Rome, Italy.",
    "Second Division of Medical Oncology, IRCCS Regina Elena National Cancer Institute, Rome, Italy.",
    "Tumor Immunology and Immunotherapy Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy paola.nistico@ifo.it."
  ]
}